Mainz Biomed N.V. announced the pricing of a follow-on offering to raise approximately $4.0 million in gross proceeds. The offering consists of 2,000,000 units, each priced at $2.00 per unit.
Each unit includes one ordinary share (or pre-funded warrant) and two warrants, Series A and Series B, both immediately exercisable at $2.00 per share. The Series A warrants expire in five years, while Series B warrants expire on the earlier of 30 days after eAArly Detect 2 results or one year.
Additionally, the company entered into a Warrant Amendment Agreement to reduce the effective strike price of both Series A and Series B warrants previously issued on December 12, 2024, to an amended exercise price of $2.00. The offering is expected to close on or about May 21, 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.